James T. Parsons, Director at ONCOLYTICS BIOTECH INC (ONCY), bought 10,000 shares at $1.03 ($10K) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Director James T. Parsons purchased 10,000 shares at $1.03, marking the largest insider purchase in the company's history. This significant accumulation comes as the stock trades near a 52-week low of $0.33, potentially signaling confidence in the company's recent FDA Fast Track designation for pelareorep.
The stock is currently trading at $0.98, down 7.55% over the last five days but still up 14.82% over the past month. It remains 35.1% below its 52-week high of $1.51, suggesting the recent insider buying could be a contrarian play on the oversold technicals.
Something here stands out, but not much.
| Filing → |